Chiplets Market Global Report 2026

The chiplets market size has grown exponentially in recent years. It will grow from $50.28 billion in 2025 to $63.05 billion in 2026 at a compound annual growth rate (CAGR) of 25.4%. The growth in the historic period can be attributed to increasing complexity in monolithic integrated circuits, escalating costs associated with advanced-node lithography, early development of 2.5D and 3D semiconductor packaging technologies, growing demand for high-performance computing, and the emergence of modular approaches to semiconductor design.

The chiplets market size is expected to see exponential growth in the next few years. It will grow to $150.96 billion in 2030 at a compound annual growth rate (CAGR) of 24.4%. The growth in the forecast period can be attributed to the expansion of AI and edge computing workloads, increasing deployment of chiplet-based data center processors, growing adoption of open chiplet standards such as UCIe, rising demand for cost-effective multi-die integration, and continued growth of semiconductor outsourcing and advanced packaging ecosystems. Major trends in the forecast period include increasing demand for heterogeneous chiplet architectures, broader adoption of standardized chiplet interconnect technologies, expansion of advanced packaging solutions for chiplet integration, increasing outsourcing of chiplet manufacturing activities, and growing emphasis on modular processor designs to shorten time to market.

The increasing prevalence of chronic and rare diseases is expected to drive the growth of the cell therapy bioreactors market in the coming years. Chronic and rare diseases encompass long-term medical conditions and uncommon disorders that frequently require specialized treatment methods, including personalized medicine and regenerative therapies. The prevalence of chronic diseases is rising substantially due to unhealthy lifestyle factors, such as inadequate diets, limited physical activity, and smoking, which increase the likelihood of developing conditions including diabetes, cardiovascular diseases, and obesity. Cell therapy bioreactors contribute to the management of chronic diseases by creating controlled environments for cultivating and expanding therapeutic cells. They improve treatment consistency and scalability by supporting reliable cell quality, facilitating personalized therapies, and enabling continued patient treatment. For instance, in 2025, according to the International Diabetes Federation, a Belgium-based health organization, approximately 589 million adults aged 20-79 were living with diabetes in 2024, and this figure is projected to increase to 853 million by 2050. Therefore, the increasing prevalence of chronic and rare diseases is driving the growth of the cell therapy bioreactors market.

Key companies operating in the chiplets market are focusing on developing new technological solutions, such as 5G technology, to strengthen their market position. 5G technology refers to the fifth generation of mobile network technology designed to provide significantly higher data speeds, ultra-low latency, greater network capacity, and more reliable connectivity compared to previous generations. For example, in 2023, Intel Corporation, a US-based technology company, launched the 4th Gen Intel Xeon Scalable processors with Intel vRAN Boost. Intel also announced the Intel Infrastructure Power Manager for 5G Core Reference Software, which provides 30% average runtime and 3 CPU power savings. Intel's hardware and software solutions enable 5G core networks to operate more efficiently while balancing critical business and customer requirements related to power efficiency, performance, and latency. This technology is expected to support the operation of 5G core networks through software while delivering cloud-native agility.

In July 2025, Tenstorrent, a U.S.-based provider of AI hardware platforms and RISC-V chiplet solutions, acquired Blue Cheetah Analog Design for an undisclosed amount. Through this acquisition, Tenstorrent sought to internalize critical analog and mixed-signal interconnect IP and engineering expertise to accelerate the development of its open chiplet ecosystem and decrease dependence on external suppliers. Blue Cheetah Analog Design is a U.S.-based start-up that specializes in customizable, standards-based die-to-die interconnect technologies and analog or mixed-signal IP solutions for chiplet architectures.

Major companies operating in the chiplets market are Samsung Electronics, Taiwan Semiconductor Manufacturing Company, Intel Corporation, IBM, Qualcomm Technologies Inc., NVIDIA Corporation, Micron Technology Inc., Advanced Micro Devices Inc., ASE Technology Holding Co. Ltd., MediaTek Inc., NXP Semiconductors N.V., United Microelectronics Corporation, GlobalFoundries, Synopsys Inc., Marvell Technology Inc., Cadence Design Systems Inc., Xilinx Inc., ALPHAWAVE SEMI, Tenstorrent, Ayar Labs Inc., Kandou Bus SA, SiFive Inc., Achronix Semiconductor Corporation, Ranovus, Netronome, X-Celeprint, NHanced Semiconductors, Rain Neuromorphics, Eliyan, Chipuller.

Asia-Pacific was the largest region in the chiplets market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the chiplets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chiplets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 1-3 business days.